PET developer Naviscan has received the CE Mark for both its high-resolution positron emission mammography (PEM) scanner and PET-guided biopsy accessory.
The approval enables the company to market the system in Europe, where it has set up distribution in 13 countries, Naviscan said. The firm has already received the first two orders for the system in Germany and Switzerland.Naviscan's PEM gets CE Mark
Latest in Nuclear Medicine
Radnostix to sell nuclear fuel processing assets for $13.5M
October 1, 2026
Eden selects Kiewit as partner for NM isotope facility
September 28, 2026
Curium gets FDA approval for Lu-177 injection for GEP-NETs
September 15, 2026

















